Omega Healthcare Investors (OHI)
(Delayed Data from NYSE)
$30.75 USD
-0.08 (-0.26%)
Updated May 9, 2024 04:00 PM ET
After-Market: $30.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$30.75 USD
-0.08 (-0.26%)
Updated May 9, 2024 04:00 PM ET
After-Market: $30.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Zacks News
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $36.45 in the latest trading session, marking a +0.64% move from the prior day.
Omega Healthcare Investors (OHI) Misses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of -3.95% and -1.58%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare (OHI) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Omega Healthcare (OHI) is likely to experience marginal growth in revenues in fourth-quarter 2018. Its strategic asset-repositioning efforts and capital-deployment measures also augur well.
Omega Healthcare Investors (OHI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $39.39, marking a -0.68% move from the previous day.
Zacks.com featured highlights include: El Pollo Loco, Jabil, Omega, Pandora Media and Talend
by Zacks Equity Research
Zacks.com featured highlights include: El Pollo Loco, Jabil, Omega, Pandora Media and Talend
Top Ranked Momentum Stocks to Buy for February 4th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 4th
Key Factors to Impact Digital Realty's (DLR) Q4 Earnings
by Zacks Equity Research
While Digital Realty (DLR) will likely gain from robust industry fundamentals and strategic acquisitions in Q4, aggressive pricing pressure and hike in interest rates remain drags.
Overcome Market Volatility With These 5 Low-Beta Stocks
by Zacks Equity Research
A low-risk portfolio can generate impressive returns if some specific parameters are considered.
Bear of the Day: Blackrock Capital
by David Borun
Reduced credit quality in the "middle market" continues to weigh on the Business Development Company
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $40.17 in the latest trading session, marking a +1.29% move from the prior day.
Key Factors to Impact AvalonBay (AVB) This Earnings Season
by Zacks Equity Research
AvalonBay's (AVB) Q4 earnings will likely benefit from the solid demand for rental units amid improving economy and job-market gains.
What's in Store for Aimco's (AIV) Earnings This Season?
by Zacks Equity Research
Though Aimco's (AIV) Q4 performance will likely reflect benefits from favorable industry fundamentals and a recovering economy, supply woes remain hurdles.
Alexandria (ARE) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
While favorable trends in the life-science real estate industry have driven Alexandria Real Estate Equities' (ARE) performance, rising financing and development costs will likely remain drags in Q4.
Can Simon Property (SPG) Pull Off a Surprise in Q4 Earnings?
by Zacks Equity Research
Simon Property's (SPG) focus on new development, redevelopment, expansion and acquisitions efforts will likely drive its Q4 performance despite the choppy retail real estate environment.
Omega Healthcare Investors (OHI) Is Up 1.99% in One Week: What You Should Know
by Zacks Equity Research
Does Omega Healthcare Investors (OHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
What's in the Cards for Kimco (KIM) This Earnings Season?
by Zacks Equity Research
While Kimco Realty (KIM) might gain from portfolio-revamp efforts and high consumer confidence amid upbeat economy, tepid retail real estate market and dispositions' dilutive impact remain concerns.
Mid-America Apartment (MAA) Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Although Mid-America Apartment (MAA) is expected to have witnessed elevated demand for its residential properties, higher interest rates might have affected the company's financing activities in Q4.
What's in the Offing for Essex Property's (ESS) Q4 Earnings?
by Zacks Equity Research
Though Essex Property's (ESS) Q4 performance will likely reflect benefits from favorable demographic trends, recovering economy and job-market growth in its markets, supply woes remain a headwind.
AGNC Investment (AGNC) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
While fresh capital enables AGNC Investment (AGNC) to improve its portfolio, spike in market volatility and rising interest rates remain growth hurdles for the company's Q4 performance.
Top Ranked Income Stocks to Buy for January 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, January 28th
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed the most recent trading day at $38.95, moving +0.96% from the previous trading session.
Equity Residential (EQR) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Equity Residential's (EQR) Q4 performance is likely to reflect benefits from strong rental housing demand, which is expected to have supported rental rate and occupancy level despite high supply.
Is Omega Healthcare Investors (OHI) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (OHI) Outperforming Other Finance Stocks This Year?
Boston Properties (BXP) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Encouraging job reports and economic improvement likely to have supported Boston Properties' (BXP) Q4 and 2018 performance. Active leasing and base rent growth remain driving factors.
Key Factors to Drive SL Green's (SLG) Earnings This Season
by Zacks Equity Research
SL Green Realty's (SLG) office portfolio will likely gain from economic improvement and job expansion. These tailwinds are anticipated to have supported rental revenue growth in the fourth quarter.